Back to DE D. E. Shaw & Co., Inc.

ARWRARWR
25 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ARROWHEAD PHARMACEUTICALS IN

D. E. Shaw & Co., Inc. holds 431,560 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $35.2M as of 2026-Q2. The position was decreased (-63.5% shares). ARWR represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$35.2M

Current Shares

431,560

Total Value Change

+$34.7M

Total Shares Change

+390,374

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
431,560
-63.5%
$35.2M0.0%$81.51
0
2026-Q1
Increased
1.2M
+710.5%
$74.2M0.0%$64.10
48
2025-Q4
Increased
146,064
+619.5%
$9.7M0.0%$67.25
45
2025-Q3
New
20,301
-
$700,1810.0%$33.78
34
2024-Q1
Exited
0
-100.0%
$00.0%$28.60
0
2023-Q4
New
45,474
-
$1.4M0.0%$30.60
35
2023-Q3
Exited
0
-100.0%
$00.0%$26.87
0
2023-Q2
Increased
31,390
+2.7%
$1.1M0.0%$35.93
26
2023-Q1
New
30,563
-
$776,3000.0%$24.43
34
2022-Q3
Exited
0
-100.0%
$00.0%$33.28
0
2022-Q2
New
8,189
-
$288,0000.0%$34.56
32
2022-Q1
Exited
0
-100.0%
$00.0%$45.59
0
2021-Q4
Decreased
33,117
-21.0%
$2.2M0.0%$67.35
0
2021-Q3
Decreased
41,906
-30.6%
$2.6M0.0%$60.63
0
2021-Q2
Increased
60,412
+36.7%
$5M0.0%$81.50
35
2021-Q1
Decreased
44,185
-50.1%
$2.9M0.0%$63.69
0
2020-Q4
Decreased
88,599
-66.3%
$6.8M0.0%$77.43
0
2020-Q3
Decreased
262,972
-39.3%
$11.3M0.0%$43.42
0
2020-Q2
Decreased
433,518
-35.9%
$18.7M0.0%$42.60
0
2020-Q1
Decreased
676,121
-2.4%
$19.5M0.0%$28.97
0
2019-Q4
Decreased
692,895
-5.9%
$44M0.1%$64.20
0
2019-Q3
Increased
736,236
+62.3%
$20.7M0.0%$26.96
41
2019-Q2
Decreased
453,605
-15.9%
$12M0.0%$26.50
0
2019-Q1
Increased
539,158
+1209.1%
$9.9M0.0%$18.35
45
2018-Q4
New
41,186
-
$512,0000.0%$11.94
33

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used